1-15 of 15
Keywords: Plasma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Transfus Med Hemother (2025) 52 (2): 111–113.
Published Online: 28 March 2025
..., instructions or products referred to in the content or advertisements. 2025 Plasma Transfusion Fresh frozen plasma and plasma-derived clotting factors are cornerstones of the transfusion therapy to resolve dysbalances in coagulation. Early transfusion of plasma could reduce mortality...
Journal Articles
Transfus Med Hemother (2023) 50 (2): 116–122.
Published Online: 12 April 2023
...Paul F.W. Strengers Background: Plasma-derived medicinal products (PDMPs) are medicinal products derived from human plasma, and a number of PDMPs are listed on the WHO Model List of Essential Medicines. These and other PDMPs are crucial for the prophylaxis and treatment of patients with immune...
Journal Articles
Transfus Med Hemother (2021) 48 (6): 377–380.
Published Online: 02 November 2021
..., instructions or products referred to in the content or advertisements. Trauma Resuscitation Whole blood Transfusion Plasma The only constant in life is change Heraclitus Dear Editor, That quotation is so true, is it not? Think back to when a physician was on call in the 1980s...
Journal Articles
Transfus Med Hemother (2021) 48 (6): 358–365.
Published Online: 14 October 2021
...Bryon P. Jackson; Jason L. Sperry; Mark H. Yazer Background: Early initiation of blood products transfusion after injury has been associated with improved patient outcomes following traumatic injury. The ability to transfuse patients’ plasma in the prehospital setting provides a prime opportunity...
Journal Articles
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Transfus Med Hemother (2014) 41 (3): 172–175.
Published Online: 12 May 2014
...Teresa Jimenez-Marco; Daniel Ruiz-Alderton; Antonia M. Bautista-Gili; Enrique Girona-Llobera Introduction: Risk reduction strategies for transfusion-related acute lung injury (TRALI) include the preferential use of male donors to provide fresh frozen plasma (FFP). Implementing this measure based...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Transfus Med Hemother (2011) 38 (1): 19–31.
Published Online: 27 January 2011
..., a comprehensive pre-clinical and clinical development and an ongoing hemovigilance program. Material and Methods: The INTERCEPT Blood System utilizes amotosalen and UVA light and enables for the treatment of platelets and plasma in the same device. Preclinical studies of pathogen inactivation and toxicology...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Transfus Med Hemother (2011) 38 (1): 43–54.
Published Online: 22 January 2011
... been developed and is under clinical evaluation for its efficacy and safety. In addition, proof of principle has been shown for UVC treatment of plasma units. The pathogen reduction process is based on application of UVC light of a specific wavelength (254 nm) combined with intense agitation...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Transfus Med Hemother (2010) 37 (3): 118–122.
Published Online: 25 May 2010
...W. Kurt Roth Upon the introduction of mandatory nucleic acid amplification technology (NAT) testing in Germany for HCV, quarantining of fresh frozen plasma (FFP) was reduced in 2002 from 6 to 4 months. In 2004 HIV-1 NAT and in 2005 anti-HBc testing were introduced to further reduce the residual...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1992) 19 (5): 232–236.
Published Online: 27 May 2009
... Kolonkarzinoms von transfundiertem Blut negativ beeinflußt wird. Besonders Plasma steht im Verdacht, immunsuppressiv zu wirken. Wir untersuchten deshalb in vitro die Wirkung von Frischplasma (FP), gefrorenem Frischplasma (GFP) und Heparin-Plasma (HP) sowie von verschiedenen i.v.-Immunglobulinen (IVIG) auf die...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1994) 21 (Suppl. 1): 7–10.
Published Online: 27 May 2009
... to in the content or advertisements. Blut Plasma Virusinfektionen Transfusionssicherheit Inaktivierung HIV 27 5 2009 ...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1994) 21 (Suppl. 1): 77–79.
Published Online: 27 May 2009
... Herpesgruppe (Cytomegalievirus, Epstein-Barr-Virus), werden ebenfalls inaktivert. Bei hüllenlosen Viren, wie z. B. Parvovirus B19 oder Picornaviren, hat das SD-Verfahren seine Grenzen, d.h., diese Viren werden nicht inaktiviert. In Blutkomponenten wie Plasma und Blutprodukten wird in Zukunft das SD-Verfahren...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie (1990) 17 (4): 220–223.
Published Online: 26 May 2009
... frozen plasma was administered during the first 5 postoperative days, containing either more than 65 μg/ml Anti-LPS in the therapy group or less than 12.5 μg/ml in the control group. The serum level of Anti-LPS was monitored. Clinical and chemical parameters were recorded to evaluate infectious...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie und Transfusionsmedizin / Infusion Therapy and Transfusion Medicine (1992) 19 (2): 84–90.
Published Online: 26 May 2009
...J.U. Wieding; H. Neumeyer Methylenblau (MB) wird seit kurzem zur Inaktivierung von Viren in Fresh-Frozen-Plasma-Einheiten (FFP) von Einzelspendern eingesetzt. In einer ersten klinischen Studie wurden 519 Einheiten eines Methylenblau-behan-delten Plasmas (MB-FFP) an 103 Patienten gegeben. Dabei...
Journal Articles
Subject Area:
Further Areas , Hematology , Oncology
Infusionstherapie und klinische Ernährung (1975) 2 (3): 182–185.
Published Online: 14 May 2009
...V. Kudlička; P. Doberský; V. Kudličková In patients who had undergone gastric operations, the efficacy of a parenteral rehabilitation with plasma, human albumin and Amino-fusin® L forte was determined by assessing the extravascular albumin pool. The intravenous administration of Aminofusin® L forte...